Skip to Main content Skip to Navigation
Journal articles

Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes

Emmanuelle Le Page 1, 2, * Gilles Edan 3, 2, 1
* Corresponding author
3 VisAGeS - Vision, Action et Gestion d'informations en Santé
INSERM - Institut National de la Santé et de la Recherche Médicale : U1228, Inria Rennes – Bretagne Atlantique , IRISA-D5 - SIGNAUX ET IMAGES NUMÉRIQUES, ROBOTIQUE
Abstract : The therapeutic arsenal for preventing multiple sclerosis (MS) relapses strongly improved over the last 20 years with more than 10 disease-modifying drugs now available. However, relapses can still occur, requiring treatment with corticosteroids to accelerate recovery...
Document type :
Journal articles
Complete list of metadata

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01559941
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Tuesday, July 11, 2017 - 9:56:15 AM
Last modification on : Friday, January 21, 2022 - 3:11:02 AM

Links full text

Identifiers

Citation

Emmanuelle Le Page, Gilles Edan. Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes. Multiple Sclerosis Journal, SAGE Publications, 2017, 23 (8), pp.1056--1058. ⟨10.1177/1352458517695893⟩. ⟨hal-01559941⟩

Share

Metrics

Les métriques sont temporairement indisponibles